retinosis.org

la rp en español

Buscar en el sitio principal de retinosis.org



Secciones en el sitio principal de retinosis.org




Boletí­n Informativo Febrero
miércoles, 2 de febrero de 2011

Retina Noticias

CONTENIDOS

Artí­culos Cientí­ficos

Noticias

Agenda (jornadas, congresos, seminarios, conferencias, cursos)

ARTíCULOS CIENTíFICOS

  • Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa

  • Texto completo

  • The future of genetic research on neurodegeneration

  • Texto completo

  • Non-viral siRNA delivery into the mouse retina in vivo

  • Texto completo

  • An Update on the Genetics of Usher Syndrome

  • Texto completo

  • Expression of connexin genes in the human retina

  • Texto completo

  • Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis

  • Texto completo

  • mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice

  • Texto completo

  • Visual acuity loss in recessive retinitis pigmentosa and its correlation with macular lesions.

  • Abstract

  • Effects of calcium ion, calpains, and calcium channel blockers on retinitis pigmentosa

  • Abstract

  • A novel mutation of RPGR gene in an X-Linked Chinese family with retinitis pigmentosa.

  • Abstract

  • Rod photoreceptor temporal properties in retinitis pigmentosa

  • Abstract

  • The Concave Iris in Pigment Dispersion Syndrome

  • Abstract

  • Drusen with Accompanying Fluid underneath the Sensory Retina

  • Abstract

  • Morphological, functional and gene expression analysis of the hyperoxic mouse retina

  • Abstract

  • Natural History of Visual Outcome in Central Retinal Vein Occlusion

  • Abstract

  • Vitreoretinal Surgery for Severe Retinal Capillary Hemangiomas in Von Hippel”“Lindau Disease

  • Abstract

  • Simultaneous Mutation Detection in 90 Retinal Disease Genes in Multiple Patients Using a Custom-designed 300-kb Retinal Resequencing Chip

  • Abstract

  • Desprendimiento de ví­treo posterior y de retina

  • Texto completo

  • Navigated photocoagulation: New era in retinal imaging, treatment

  • Artí­culo completo

  • Glaucoma: Recent Discoveries and Patient Care

  • Abstract

  • Retinal pigment epithelial cells upregulate expression of complement factors after co-culture with activated T cells

  • Abstract

  • Anti”“Retinal Pigment Epithelium Antibodies in Acute Exudative Polymorphous Vitelliform Maculopathy

  • Abstract

  • Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina

  • Abstract

  • A hybrid bioorganic interface for neuronal photoactivation

  • Abstract

  • Development of asymmetric inhibition underlying direction selectivity in the retina

  • Abstract

  • Bardet”“Biedl syndrome highlights the major role of the primary cilium in efficient water reabsorption

  • Abstract

  • Neuroimmunology: Immune input for retinal repair

  • Abstract

  • Long-term Retinal Function and Structure Rescue Using Capsid Mutant AAV8 Vector in the rd10 Mouse, a Model of Recessive Retinitis Pigmentosa

  • Abstract

    NOTICIAS

  • VIII Convocatoria para la adjudicación de Ayudas a Proyectos de Investigación Médica 2011

    DOS PREMIOS DOTADOS CON 3.000 EUR cada uno al mejor trabajo de investigación publicado en revistas nacionales o internacionales durante el año 2010, en temas relacionados con politraumatismos, trasplante de órganos, oncologí­a médico-quirúrgica y cualquier otro relacionado con las ciencias médicas.
    Noticia completa

  • Otro paso hacia la creación de una retina artificial orgánica

    Un estudio realizado en Italia marca otro avance hacia a la creación de una retina artificial orgánica, eléctricamente autónoma y con una eficiencia comparable a la humana.
    El trabajo para la puesta a punto del prototipo, con la autorí­a del Departamento de neurociencias y neurotecnologí­as (NBT) del Centro de nano-ciencias y tecnologí­as del Instituto italiano de Tecnologí­a (CNST – IIT) y del Departamento de fí­sica del Politécnico de Milán, fue publicado ayer en la revista Nature y fue coordinado por Guglielmo Lanzni del CNST.
    Noticia completa

  • El genoma murino, clave para neurodegenerativas

    Uno de los grandes retos en investigación biomédica es la generación de modelos animales que respondan lo más fielmente posible a las preguntas experimentales sobre enfermedades del hombre. En este contexto, el proyecto europeo Eucommtools (Herramientas para la anotación funcional del genoma del ratón) se ha convertido en la mayor iniciativa mundial para determinar la expresión del genoma del ratón y generar modelos animales de enfermedades genéticas.
    Noticia completa

  • EEUU aprueba ensayos con células madre para tratar ceguera por maculopatí­a

    El ensayo examinará las posibilidades que tiene esta terapia de tratar de forma segura a personas que padecen degeneración macular relacionada a la edad, que es la forma más común de pérdida de visión irreversible en mayores de 60 años. Actualmente no existe cura para esta enfermedad que afecta a entre 10 y 15 millones de estadounidenses y a 10 millones de personas en Europa, informó la empresa.
    Noticia completa

  • La genética y los estudios en colaboración, futuro en Usher

    El Simposio Internacional del Sí­ndrome de Usher y Enfermedades Relacionadas, celebrado en Valencia, ha reunido a expertos de diferentes disciplinas y ámbitos de investigación para analizar la situación actual y perspectivas futuras de esta patologí­a
    Noticia completa

  • Unexpected Biological Pathway in Glaucoma: Study Pinpoints Precise Anatomical Location Where Vision Loss Appears to Occur

    In a study published in the Proceedings of the National Academy of Sciences, a team of researchers from the Kennedy Krieger Institute and four collaborating institutions, identified a new and unexpected biological pathway that appears to contribute to the development of glaucoma and its resulting vision loss.
    Noticia completa

  • New Glaucoma Test Allows Earlier, More Accurate Detection

    Cumbersome glaucoma tests that require a visit to the ophthalmologist could soon be history thanks to a home test developed by a UA engineer.
    Noticia completa

  • Manchester Scientists Discover New Way Of Seeing

    University of Manchester scientists have found that a new type of light sensitive cell (photoreceptor) in the eye helps the brain measure brightness. This mechanism, which works alongside the rod and cone photoreceptors, may be important for people with certain types of blindness.

    Noticia completa

  • Researchers Achieve Extensive Regeneration In Nerve Connecting Eye To Brain

    Damage to the optic nerve, connecting the eye with the brain, is a major cause of blindness. The most common culprit is glaucoma, estimated to affect more than 4 million Americans. There is currently no way to restore the lost vision, because the optic nerve, like other nerves in the mature central nervous system (CNS), cannot regenerate. Now, scientists at Children’s Hospital Boston report achieving the greatest regeneration to date in the mammalian optic nerve.
    Noticia completa

  • Lucentis(R) (Ranibizumab) Launched For Vision Loss Due To Diabetic Macular Oedema, A Serious And Common Complication Of Diabetes

    Novartis Pharmaceuticals UK Ltd announced that Lucentis® (ranibizumab) has launched in the UK for the treatment of visual impairment due to diabetes, specifically diabetic macular oedema (DMO). This offers fresh hope for people with this serious and common complication of diabetes.
    Noticia completa

  • InSite Vision Completes Patient Enrollment In ISV-303 Phase 1/2 Clinical Study For Post-Surgical Ocular Pain And Swelling

    InSite Vision Incorporated (OTCBB:INSV), a company developing novel ophthalmic therapeutics, has announced that patient enrollment was recently completed in the company’s Phase 1/2 clinical trial of ISV-303, a novel compound being developed to reduce the pain and inflammation associated with ocular surgery. ISV-303 combines a low dose of the non-steroidal anti-inflammatory (NSAID) bromfenac (BROMDAYâ„¢/Xibromâ„¢ marketed by ISTA Pharmaceuticals) with InSite Vision’s proprietary DuraSite® technology.
    Noticia completa

  • Enzyme Inhibition Or Removal May Prevent Or Treat Ischemic Retinopathy

    The inhibition or removal of an enzyme may prevent or treat ischemic retinopathy by stalling growth of unwanted vessels in the retina, Medical College of Georgia researchers say.
    Noticia completa

  • Melanopsin Looks On The Bright Side Of Life

    Better known as the light sensor that sets the body’s biological clock, melanopsin also plays an important role in vision: Via its messengers-so-called melanopsin-expressing retinal ganglion cells, or mRGCs-it forwards information about the brightness of incoming light directly to conventional visual centers in the brain, reports an international collaboration of scientists in this week’s issue of PLoS Biology.
    Noticia completa

  • Vision science: Seeing without seeing

    There is more to the eye than rods and cones ”” the discovery of a third photoreceptor is rewriting the visual rulebook.Russell Foster remembers his first human subject, an 87-year-old woman, as she sat in a dark room facing a backlit pane of frosted glass. A genetic disorder had destroyed the light-sensing rod and cone cells in her eyes, leaving her blind for the past 50 years. She was convinced that she would see nothing. But as the wavelength of light in the room shifted to blue, she reported ”” after some hesitation ”” a sort of brightness.
    Noticia completa

  • UK Medical Student Ophthalmology Teaching Falling Short

    UK medical schools are failing to comply with the recommended curriculum for ophthalmology, set out by the International Council of Ophthalmologists (ICO), suggests a survey published online in the British Journal of Ophthalmology.
    Noticia completa

  • Alkeus Pharmaceuticals Licenses Novel Ophthalmologic Therapies From Columbia University With Applications In Dry-AMD And Stargardt’s Disease

    Alkeus Pharmaceuticals and Columbia University announced today that they have entered into a license agreement for a set of potential therapies for the treatment of dry age-related macular degeneration (dry-AMD), Stargardt disease, and other degenerative diseases of the eye. Left untreated, these conditions often lead to impaired vision and even blindness.
    Noticia completa

  • Advanced Cell Technology Receives FDA Clearance For Clinical Trials Using Embryonic Stem Cells To Treat Age-Related Macular Degeneration

    Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTC), a leader in the field of regenerative medicine, announced that the US Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to treat Dry Age-Related Macular Degeneration (AMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs). ACT is now permitted to initiate a Phase I/II multicenter clinical trial to treat patients with Dry AMD, the most common form of macular degeneration in the world. There are currently no treatments available for this prevalent disease of an aging global population. Dry AMD, representing a substantial global market opportunity and afflicts between 10-15 million Americans.
    Noticia completa

  • Software releases researchers from microscope

    EU-funded scientists have developed a system that releases researchers from the chore of spending hours hunched over a microscope looking for cells of interest in large samples. The system is described in the journal Nature Methods by a team led by the European Molecular Biology Laboratory (EMBL) in Germany.
    Noticia completa

  • Implant Appears Effective For Treating Inflammatory Disease Within The Eye

    An implant that releases the medication dexamethasone within the eye appears safe and effective for the treatment of some types of uveitis (swelling and inflammation in the eye’s middle layer), according to a report posted online today that will appear in the May print issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
    Noticia completa

  • AGENDA

  • 2nd Annual Diabetes and Diabetic Retinopathy Conference
  • Fecha: desde el 07/02/11 hasta 08/02/11

    Dónde: Londres

    Web:Bioportfolio

    Visiongain de2da Edición de la diabetes y la conferencia de la retinopatí­a diabética está diseñado para reunir a los expertos de la industria para discutir todos los aspectos del desarrollo de medicamentos para la diabetes, de la última a través de desarrollo clí­nico para tratar con las cuestiones reglamentarias.

  • Cogreso de Oftalmologí­a
  • Fecha: desde el 3 al 5 de febrero

    Dónde:Elche

    Web:Facoelche

    Desde 1999, el Congreso facoElche es una reunión cientí­fica anual que se celebra durante el primer fin de semana de febrero, en el Hotel Huerto del Cura de Elche, y a la que acuden más de 600 oftalmólogos y profesionales de la visión de toda España y de muchos paí­ses extranjeros.
    Actualmente, FacoElche se ha consolidado como la tercera reunión cientí­fica más importante a nivel de Oftalmologí­a, realizada de forma regular en España, tras la de las dos sociedades oficiales principales.

  • 2º Congreso Mundial sobre Controversias en Oftalmologí­a
  • Fecha: del 03 al 06 de marzo de 2011

    Dónde:Barcelona(Palacio de Congresos de Cataluña)

    Web:Comtecmed

  • Congreso 2011 de la Sociedad Española de Glaucoma
  • Fecha: desde el 17/03/11 hasta 19/03/11

    Dónde:Madrid

    Web:Sociedad Española de Glaucoma

  • XV Congreso Sociedad Española de Retina y Ví­treo
  • Fecha: 4 y 5 de marzo

    Dónde:Palacio Municipal de Congresos de Madrid.

    Web:SERV

  • V Congreso Internacional de Medicamentos Huérfanos y Enfermedades Raras
  • Fecha: desde el 17/02/11 hasta 19/02/11

    Dónde:Sevilla

    Web:Feder

    La Federación Española de Enfermedades Raras y el Colegio de Farmacéuticos de Sevilla organizan el V Congreso Internacional de Medicamentos Huérfanos y Enfermedades Raras, del 17 al 19 de febrero de 2011 en Sevilla.
    El lema: “Uniendo esfuerzos frente a las enfermedades raras” resume el objetivo principal de la nueva edición. Es el momento de valorar el esfuerzo realizado en años anteriores y plantear un nuevo reto que ayude a conseguir un mayor beneficio para aquellos que se ven afectados por estas enfermedades.

  • A Decade with the Human Genome Sequence: Charting a Course for Genomic Medicine
  • Fecha: 11 de febrero

    Dónde:National Institutes of Health

    Web:Genome

    The past year has been a particularly special one for the field of genomics and for the National Human Genome Research Institute (NHGRI). This year has brought the 20th anniversary of the start of the Human Genome Project and the 10th anniversary of having in hand a draft sequence of the human genome. It also marks the end of a roughly 2-year planning process for the NHGRI, the output of which will be published as a new “strategic vision for genomics” in February 2011.

    Deja tu comentario